NSE: MPHASIS | BSE: 526299

Mid-range Performer

Download real time

2736.40 -40.80 (-1.47%)

33.84% Gain from 52W Low

413.1K NSE+BSE Volume

NSE 23 Jul, 2025 3:31 PM (IST)

52,012.6

Market Cap

High in industry

1.5

Beta 1Year

Very High Volatility

Board Meeting

The next board meeting for MphasiS Ltd. is on 24 Jul 2025 for the purpose of Quarterly Results See details

MphasiS Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for MPHASIS, BSE:526299 MphasiS Ltd.

MphasiS Ltd.

15 May 2021

2736.40

-1.47%

Direct business to drive performance

Buy: MphasiS Ltd.

Target

Motilal Oswal

MPHL's 4QFY21 revenue growth was led by 3.5% CC QoQ growth in the Direct business, while DXC vertical (12% of revenue, -7.7% QoQ CC) remains a drag. EBIT margin dip of 30bp QoQ was due to higher sales investments. It won USD245m of new deals in 4QFY21, and announced its largest ever...

Number of FII/FPI investors decreased from 1016 to 986 in Jun 2025 qtr

MphasiS Ltd.

14 May 2021

2736.40

-1.47%

Q4FY21 Result Update - Steady quarter with improving deal pipeline - BUY

Buy: MphasiS Ltd.

Target

Prabhudas Lilladhar

Won a landmark 10-year, $250 mn deal (largest deal in its history) in 1QFY22E. Revenues came at $342.2 Mn +2.5% QoQ USD slightly above our estimate (Ple: 2.3%) led by lower than anticipated decline in DXC, -7.2% QoQ USD (Ple: -10%) and sustained strong growth momentum in Direct channel (+3.1% QoQ...

MphasiS Ltd. is trading below its 30 day SMA of 2793.6

MphasiS Ltd.

14 May 2021

2736.40

-1.47%

Mphasis (SELL): DXC drag to continue; cut to SELL

Sell: MphasiS Ltd.

Target

BOB Capital Markets Ltd.

Mphasis (MPHL) reported dollar revenue growth of 1.8% QoQ in Q4FY21, underperforming our estimate.

MphasiS Ltd. is trading above its 200 day SMA of 2716.8

MphasiS Ltd.

14 May 2021

2736.40

-1.47%

Mphasis Limited

Buy: MphasiS Ltd.

ICICI Securities Limited

The company's strategy to mine top10/20 clients and adding high potential new logos bodes well for growth in direct channel. This coupled with management stability, improving deal size, market share gains via vendor consolidation, low legacy exposure, exposure to lesser impacted vertical and healthy margins prompt us to be positive on the stock from a long term perspective. However, run up in price and uncertainty on DXC revenues prompt us to downgrade the stock from BUY to HOLD with a target price of...

MphasiS Ltd. is trading below its 30 day SMA of 2793.6

MphasiS Ltd.

27 Apr 2021

2736.40

-1.47%

Event Update - Blackstone continuity reinstates growth outlook - BUY

Buy: MphasiS Ltd.

Target

Prabhudas Lilladhar

Mphasis on 26th April 2021 announced that Blackstone entered into a definitive agreement to transfer 55% shareholding in Mphasis from its existing PE fund (Marble II PTE) to a different Blackstone PE fund (BCP Topco IX Pte). Blackstone also brought along marquee long term co-investors - Abu...

MphasiS Ltd. is trading above its 200 day SMA of 2716.8

MphasiS Ltd.

26 Apr 2021

2736.40

-1.47%

Mphasis Limited

Buy: MphasiS Ltd.

Target

ICICI Securities Limited

This transaction has triggered an open offer by the acquirer. The acquirer has announced an open offer for acquisition of up to ~4.92 crore shares at | 1677/share amounting to ~ 8,261 crore shares. We believe the stock has...

MphasiS Ltd. is trading above its 200 day SMA of 2716.8

MphasiS Ltd.

25 Jan 2021

2736.40

-1.47%

Q3FY21 Result Update - Direct channel to power growth - BUY

Buy: MphasiS Ltd.

Target

Prabhudas Lilladhar

Strong deal wins (FYTD TCV of 867mn; +64.0% YoY), deal pipeline up +50% YoY provide growth visibility for FY22 for Direct business. Mphasis negatively surprised us due to soft growth in revenues at 333.9$ Mn, +2% QoQ USD (Ple: 2.7% QoQ CC, 3% QoQ USD) led by 17.5% decline in DXC...

Number of FII/FPI investors decreased from 1016 to 986 in Jun 2025 qtr

MphasiS Ltd.

22 Jan 2021, 12:00AM

2736.40

-1.47%

Mphasis (REDUCE): DXC revenue contracts further; BFS growth slows

Sell: MphasiS Ltd.

Target

BOB Capital Markets Ltd.

Mphasis (MPHL) reported dollar revenue growth of 2% QoQ in Q3FY21, in line with estimates but lagging behind peers.

MphasiS Ltd. is trading above its 200 day SMA of 2716.8

MphasiS Ltd.

22 Jan 2021, 12:00AM

2736.40

-1.47%

Mphasis Ltd.

Buy: MphasiS Ltd.

Target

ICICI Securities Limited

The company has seen healthy deal win in direct channel of US$247 million of which 71% is in New-gen services. In addition, FYTD TCV wins has increased by 64% YoY to US$867 million. Apart from healthy deal wins the company has witnessed increase in deal in size of wins (almost doubled on YoY basis) and the tenure has also increased which we believe bodes well for long term revenue growth. In addition, the company has successfully mined clients leading to addition of 1 client on YoY basis in US$75 million category and 2 in US$20 million category. Further, the company is also...

Number of FII/FPI investors decreased from 1016 to 986 in Jun 2025 qtr

MphasiS Ltd.

26 Oct 2020

2736.40

-1.47%

Q2FY21 Result Update - Strong, Steady, Resilient! - BUY

Buy: MphasiS Ltd.

Recommendation Target

Prabhudas Lilladhar

QoQ CC / 18.4% YoY CC / 7.2% QoQ USD (Ple: 3% QoQ CC, 3.9% QoQ USD). Direct Channels grew at a robust 10.9% QoQ CC contributing 83.8% to revenues while DXC channel revenues declined 15.5% QoQ. Growth was led by banking and capital markets that grew a remarkable 17% QoQ. EBIT margin (pre-forex impact) at 16.2% grew at modest rate (+45 bps QoQ) and was in-line with our estimates (Ple: 16%). Margin band was maintained at 15.516.5% & aspiring to grow above that also. Mphasis won new deals with TCV of USD 360 million in Q2 FY21 with 73 % of the deal wins in New-Gen Services, TCV on ttm basis is at US$1 bn, up 75%...

MphasiS Ltd. is trading above its 200 day SMA of 2716.8

Is MphasiS Ltd. worth buying?

246 Votes:

Buy 78.86%

Sell 12.2%

Hold 8.94%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf